XML 65 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Measurements [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value

The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the years ended December 31, 2023 and 2022, there were no transfers between Levels 2 and 3.

   December 31, 2024
   Total  Level 1  Level 2  Level 3
Assets:            
Recurring fair value measurements:                    
Cash equivalents  $48,336   $48,336   $
   $
 
Financial instruments owned, at fair value:                    
ETFs   62,907    62,907    
    
 
Pass-through GSEs   6,898    
    6,898    
 
Other assets—seed capital (WisdomTree Digital Funds):                    
U.S. treasuries   5,251    
    5,251    
 
Equities   8,478    8,478    
    
 
Fixed income   1,905    1,019    886    
 
Other investments   687    
    
    687 
Total  $134,462   $120,740   $13,035   $687 
Non-recurring fair value measurements:                    
Fnality International Limited—Series B-1 Preference Shares(1)  $8,288   $
   $
   $8,288 
(1) Fair value determined on June 17, 2024. Not included above are prospective changes in value due to fluctuations in the British pound to U.S. dollar exchange rate.
   December 31, 2023
   Total  Level 1  Level 2  Level 3
Assets:            
Recurring fair value measurements:                    
Cash equivalents  $50,226   $50,226   $
   $
 
Financial instruments owned, at fair value:                    
ETFs   35,181    35,181    
    
 
Pass-through GSEs   10,240    
    10,240    
 
Other assets—seed capital (WisdomTree Digital Funds):                    
U.S. treasuries   5,007    
    5,007    
 
Equities   6,337    6,337    
    
 
Fixed income   1,957    1,008    949    
 
Total  $108,948   $92,752   $16,196   $
 
Non-recurring fair value measurements:                    
Fnality International Limited—Series B-1 Preference Shares(1)   9,684    
    
    9,684 
Other investments(2)   
    
    
    
 
Total  $9,684   $
   $
   $9,684 

(1) Fair value determined on October 31, 2023

(2) Fair value determined on September 30, 2023

Schedule of Instruments

These instruments consist of the following:

   Years Ended
  

December 31,
2024

 

December 31,
2023

Other Investments:          
Beginning balance  $
   $
 
Purchases   674    
 
Net unrealized gains(1)   13    
 
Ending balance  $687   $
 
Investments in Convertible Notes:          
Beginning balance  $
   $21,421 
Purchases   
    11,228 
Settlements   
    (28,818)
Conversions(2)   
    (9,684)
Net realized gains(3)   
    5,853 
Ending balance  $
   $
 
Deferred Consideration (Note 9):          
Beginning balance  $
   $200,290 
Net realized losses(4)   
    6,069 
Net unrealized gains(5)   
    (61,953)
Settlements   
    (144,406)
Ending balance  $
   $
 
(1) Recorded in impairments and other gains/(losses), net in the Consolidated Statements of Operations.
(2) The Fnality convertible notes converted into Series B-1 Preference Shares on October 31, 2023 (Note 7).
(3) Recorded in impairments and other gains/(losses), net in the Consolidated Statements of Operations.
(4) Recorded as contractual gold payments expense in the Consolidated Statements of Operations.
(5) Recorded as gain on revaluation/termination of deferred considerationgold payments in the Consolidated Statements of Operations.